// App-Quantinova.ai

297.0 : Multivariate assessment of SPARC expression in resected pancreatic ductal adenocarcinoma to identify subgroups that are sensitive to adjuvant gemcitabine.

Researchers

Presenter

  • Steve Kalloger

Principal Investigators

  • Joanna Karasinska

  • Hui-li Wong

  • Daniel John Renouf

  • David F. Schaeffer

Medical Centers

  • Pancreas Centre BC, Vancouver, BC, Canada

  • BC Cancer Agency, Vancouver, BC, Canada

  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada

  • Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Osteonectin

Drug/Treatment

  • Gemcitabine

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A